Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial.


Journal

Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 21 05 2018
accepted: 09 07 2018
pubmed: 15 7 2018
medline: 11 7 2019
entrez: 15 7 2018
Statut: ppublish

Résumé

Prospective randomized trial to compare standard vs delayed approach to dorsal vascular complex (s-DVC vs d-DVC) in robot-assisted radical prostatectomy (RARP). Patients scheduled for RARP were randomized into a 1:1 ratio to receive either s-DVC or d-DVC by two experienced surgeons. In s-DVC arm an eight-shaped single stitch was given at the beginning of the procedure and the DVC was subsequently cut at time of apical dissection; in d-DVC arm the plexus was transected at the end of prostatectomy, prior to apex dissection and then sutured. Primary endpoint was difference in estimated blood loss (EBL) and a sample size of 226 cases was calculated; ad interim analysis was planned after 2/3 of recruitment. Endpoint was reached at ad interim analysis after 162 cases (81 s-DVC, 81 d-DVC) and recruitment was, therefore, interrupted. Baseline and tumor characteristics were overlapping. EBL was significantly higher in d-DVC arm (mean EBL 107 vs 65 ml, p = 0.003), but without differences in post-operative hemoglobin, transfusions and complications. Overall PSM rate was higher in d-DVC arm (21.0 vs 14.8%, p = 0.323), with statistical significance relatively to organ-confined disease (15.5 vs 3.6%, p = 0.031). Apical involvement was instead significantly higher in s-DVC arm (prevalence in PSM patients 66.7 vs 23.5%, p = 0.020). Post-operative PSA, continence and potency rates were similar between groups. Standard and delayed approaches to DVC are safe and lead to similar functional outcomes. A delayed approach exposes to a higher risk of PSM in organ-confined disease but with a lower risk of apical involvement.

Identifiants

pubmed: 30006861
doi: 10.1007/s11701-018-0847-9
pii: 10.1007/s11701-018-0847-9
doi:

Types de publication

Clinical Trial, Phase III Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-260

Références

Clin Perform Qual Health Care. 1993 Oct-Dec;1(4):219-22
pubmed: 10135639
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur Urol. 2009 Jun;55(6):1377-83
pubmed: 19243886
BJU Int. 2010 Aug;106(3):385-90
pubmed: 20067457
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Eur Urol. 2011 Feb;59(2):235-43
pubmed: 20863611
Minerva Urol Nefrol. 2010 Sep;62(3):295-304
pubmed: 20940698
J Endourol. 2012 Dec;26(12):1605-8
pubmed: 22691123
Int J Urol. 2013 May;20(5):493-500
pubmed: 23039276
Can J Urol. 2013 Dec;20(6):7079-83
pubmed: 24331354
Urology. 2014 Dec;84(6):1453-8
pubmed: 25432837
Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):7-11
pubmed: 26399124
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Eur Urol. 2016 Aug;70(2):301-11
pubmed: 26850969
Eur Urol. 2016 Nov;70(5):837-845
pubmed: 26874806
World J Urol. 2017 Mar;35(3):395-402
pubmed: 27380209
Lancet. 2016 Sep 10;388(10049):1057-1066
pubmed: 27474375
Minerva Urol Nefrol. 2017 Feb;69(1):63-68
pubmed: 28009146
Eur Urol. 2017 Oct;72(4):632-640
pubmed: 28412062
Eur Urol Focus. 2018 Jul;4(4):608-613
pubmed: 28753862
BJU Int. 2018 Jun;121(6):845-853
pubmed: 29063728
Br J Cancer. 2018 Feb 20;118(4):489-494
pubmed: 29348490
NCI Monogr. 1988;(7):133-7
pubmed: 3173499
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Am Coll Surg. 1997 Oct;185(4):315-27
pubmed: 9328380

Auteurs

Alessandro Antonelli (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Carlotta Palumbo (C)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy. palumbo.carlotta@gmail.com.

Alessandro Veccia (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Simona Fisogni (S)

Department of Pathology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Stefania Zamboni (S)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Maria Furlan (M)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Simone Francavilla (S)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Marco Lattarulo (M)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Enrico De Marzo (E)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Giuseppe Mirabella (G)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Angelo Peroni (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Claudio Simeone (C)

Department of Urology, Spedali Civili Hospital, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH